I have been taking lorazepam 0.5 mg daily for about 11 days and was given a total of 15 mg diazepam (Valium) as a taper; how should I safely discontinue lorazepam and taper the diazepam?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Benzodiazepine Discontinuation After Short-Term Use

For 11 days of lorazepam 0.5 mg daily with 15 mg total diazepam available, you can safely stop the lorazepam immediately and use the diazepam as a brief taper over 3-7 days, or simply discontinue both without a taper given the very short duration of use.

Rationale for This Approach

After only 11 days of low-dose benzodiazepine use, you have minimal risk of clinically significant physical dependence. The FDA labeling for lorazepam emphasizes that withdrawal reactions are primarily a concern in patients taking "higher dosages" and those with "longer durations of use" 1. Your situation involves neither—0.5 mg daily is a low dose and 11 days is a very short duration.

Specific Discontinuation Options

Option 1: Direct Discontinuation (Preferred)

  • Stop lorazepam immediately without substitution
  • Reserve the 15 mg diazepam supply in case mild anxiety or insomnia emerges
  • Use diazepam only if needed: 2-5 mg once or twice daily for 2-3 days maximum
  • This approach is reasonable because physical dependence is unlikely after such brief exposure

Option 2: Brief Diazepam Taper (Conservative)

If you prefer extra caution or have anxiety about stopping:

Days 1-2: Diazepam 5 mg once daily (evening)
Days 3-4: Diazepam 2.5 mg once daily (evening)
Days 5-7: Diazepam 2 mg once daily (evening), then stop

This uses approximately 13-14 mg of your 15 mg supply and provides a gentle transition.

Why This Differs from Long-Term Use Guidelines

The evidence you're seeing about gradual tapers applies to long-term users (months to years). The 2016 CDC guidance specifically states that "a commonly used tapering schedule that has been used safely and with moderate success is a reduction of the benzodiazepine dose by 25% every 1–2 weeks" 2, but this recommendation is for patients with established dependence.

Research on benzodiazepine withdrawal delirium shows that severe complications occur primarily in patients with chronic use patterns ranging from "6 weeks to 50 years" of exposure 3. Your 11-day exposure falls well below even the shortest duration associated with complicated withdrawal.

What to Monitor

Watch for mild rebound symptoms over the next 3-5 days:

  • Temporary increase in anxiety (should be mild)
  • Transient sleep difficulty
  • Mild restlessness

These are NOT dangerous withdrawal symptoms—they represent your baseline anxiety returning, not physical dependence.

Red Flags That Would Change This Approach

You would need a more cautious taper if you had:

  • Previous history of benzodiazepine dependence
  • History of alcohol use disorder (cross-tolerance exists) 4
  • Seizure history
  • Current use of other CNS depressants, particularly opioids 2, 1

None of these appear to apply based on your question.

Critical Safety Point

Do not restart lorazepam or continue benzodiazepines beyond this brief taper. The FDA labeling warns that benzodiazepines "expose users to the risks of abuse, misuse, and addiction" 1, and even short-term use can evolve into problematic long-term use. The 15 mg diazepam you have is more than adequate—do not seek additional prescriptions.

Why Diazepam for Tapering?

If you choose to taper, diazepam is appropriate because it has a long half-life (20-100 hours) and active metabolites that provide smooth coverage, reducing the risk of interdose withdrawal symptoms that can occur with short-acting lorazepam 5. However, given your brief exposure, this pharmacokinetic advantage is less critical than it would be for long-term users.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.